| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4005601 | American Journal of Ophthalmology | 2007 | 10 Pages |
Abstract
Low-dose MMC (0.002%) in eyes after LASEK results in less corneal haze than in eyes not receiving this agent. Concerns regarding the potential toxicity of MMC make a 10-fold less concentration more desirable in refractive surgery. Further comparative study of low- vs higher-dose MMC is recommended to characterize its clinical benefit fully.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Ivey Thornton, Ashok Puri, Meng Xu, Ronald R. Krueger,